Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1982 2
1983 1
1984 2
1985 4
1986 7
1987 6
1988 1
1989 5
1990 3
1991 2
1992 9
1993 6
1994 7
1995 9
1996 10
1997 7
1998 7
1999 15
2000 12
2001 7
2002 10
2003 6
2004 7
2005 6
2006 6
2007 4
2008 4
2009 1
2010 4
2011 4
2012 4
2013 1
2014 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

177 results

Results by year

Filters applied: . Clear all
Page 1
PhRMA white paper on ADME pharmacogenomics.
Williams JA, Andersson T, Andersson TB, Blanchard R, Behm MO, Cohen N, Edeki T, Franc M, Hillgren KM, Johnson KJ, Katz DA, Milton MN, Murray BP, Polli JW, Ricci D, Shipley LA, Vangala S, Wrighton SA. Williams JA, et al. Among authors: wrighton sa. J Clin Pharmacol. 2008 Jul;48(7):849-89. doi: 10.1177/0091270008319329. Epub 2008 Jun 4. J Clin Pharmacol. 2008. PMID: 18524998 Review.
The human drug metabolizing cytochromes P450.
Wrighton SA, VandenBranden M, Ring BJ. Wrighton SA, et al. J Pharmacokinet Biopharm. 1996 Oct;24(5):461-73. doi: 10.1007/BF02353474. J Pharmacokinet Biopharm. 1996. PMID: 9131485 Review.
The human CYP3A subfamily: practical considerations.
Wrighton SA, Schuetz EG, Thummel KE, Shen DD, Korzekwa KR, Watkins PB. Wrighton SA, et al. Drug Metab Rev. 2000 Aug-Nov;32(3-4):339-61. doi: 10.1081/dmr-100102338. Drug Metab Rev. 2000. PMID: 11139133 Review. No abstract available.
The role of CYP2B6 in human xenobiotic metabolism.
Ekins S, Wrighton SA. Ekins S, et al. Among authors: wrighton sa. Drug Metab Rev. 1999 Aug;31(3):719-54. doi: 10.1081/dmr-100101942. Drug Metab Rev. 1999. PMID: 10461547 Review. No abstract available.
Progress in predicting human ADME parameters in silico.
Ekins S, Waller CL, Swaan PW, Cruciani G, Wrighton SA, Wikel JH. Ekins S, et al. Among authors: wrighton sa. J Pharmacol Toxicol Methods. 2000 Jul-Aug;44(1):251-72. doi: 10.1016/s1056-8719(00)00109-x. J Pharmacol Toxicol Methods. 2000. PMID: 11274894 Review.
The conduct of in vitro and in vivo drug-drug interaction studies: a PhRMA perspective.
Bjornsson TD, Callaghan JT, Einolf HJ, Fischer V, Gan L, Grimm S, Kao J, King SP, Miwa G, Ni L, Kumar G, McLeod J, Obach SR, Roberts S, Roe A, Shah A, Snikeris F, Sullivan JT, Tweedie D, Vega JM, Walsh J, Wrighton SA; Pharmaceutical Research and Manufacturers of America Drug Metabolism/Clinical Pharmacology Technical Working Groups. Bjornsson TD, et al. Among authors: wrighton sa. J Clin Pharmacol. 2003 May;43(5):443-69. J Clin Pharmacol. 2003. PMID: 12751267 Review.
177 results